Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Outlook Therapeutics Inc (NASDAQ: OTLK) was $1.59 for the day, up 3.92% from the previous closing price of $1.53. In other words, the price has increased by $3.92 from its previous closing price. On the day, 0.75 million shares were traded.
Ratios:
Our analysis of OTLK’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.26 and its Current Ratio is at 0.32.
On March 27, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $50.
Chardan Capital Markets Upgraded its Neutral to Buy on February 15, 2024, while the target price for the stock was maintained at $3.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 26 ’24 when KENYON LAWRENCE A bought 5,000 shares for $5.69 per share. The transaction valued at 28,446 led to the insider holds 5,946 shares of the business.
Stock Price History:
Over the past 52 weeks, OTLK has reached a high of $9.25, while it has fallen to a 52-week low of $0.87. The 50-Day Moving Average of the stock is 11.37%, while the 200-Day Moving Average is calculated to be -57.07%.
Shares Statistics:
A total of 24.91M shares are outstanding, with a floating share count of 20.52M. Insiders hold about 37.11% of the company’s shares, while institutions hold 16.56% stake in the company.
